A Novel Interruption Management Intervention for New Graduate Nurses During Medication Administration
2 other identifiers
interventional
56
1 country
1
Brief Summary
The objective of this study was to evaluate the effect of education in the Stay S.A.F.E. interruption management strategy on nurses' responses to interruptions during simulated medication administration. Primary outcomes included 1) response to the interrupter, including adherence to Stay S.A.F.E. behaviors, and 2) time away from the primary task. Secondary outcomes included 1) medication administration errors and 2) perceived workload as measured by the NASA Task Load Index.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 13, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 25, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 25, 2024
CompletedFirst Submitted
Initial submission to the registry
May 11, 2026
CompletedFirst Posted
Study publicly available on registry
May 20, 2026
CompletedMay 20, 2026
May 1, 2026
5 months
May 11, 2026
May 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Response to Interrupter Using the Stay S.A.F.E. Strategy
The primary outcome is the participant's response to a clinical interruption, assessed using an eye tracking device (ETD). Study personnel recorded interruption management behaviors, Stay S.A.F.E., using a structured data collection tool and whether the participant immediately accepted the interruption ("took report").
During simulation (immediate assessment at interruption; within a 30 minute session)
Time away from primary task
Time away from the primary medication-administration task is measured using eye tracking device (ETD) recordings. Two trained study team members review recorded sessions to determine the duration between the onset of the interruption and the participant's return to the primary task, defined as the point at which the participant's ETD crosshairs re-engage with the medication-administration activity. Time is calculated using timestamp data captured within the ETD recordings.
During simulated interruption event (from onset of interruption to return to primary task; within a 30-minute session)
Secondary Outcomes (2)
medication administration errors
During simulation (real-time assessment with post-simulation validation; up to 30 minutes).
Perceived Workload (NASA Task Load Index)
Immediately following the simulation (within a 30-minute session).
Study Arms (2)
Stay S.A.F.E. Interruption Management Education
EXPERIMENTALMedication Safety Education
SHAM COMPARATORInterventions
The Stay S.A.F.E. strategy is a structured, behavioral approach designed to support task focus and safe task resumption during interruptions. It consists of the following steps: Stay physically in the current location and remain engaged in the primary task; when possible, physically hold task-related items. Say aloud what you are doing at the moment of interruption, being as specific as possible while maintaining patient privacy. Acknowledge the person interrupting you without looking away from the primary task. Fixate visually and cognitively on the current place in the task for one to two seconds and identify a natural stopping point. Estimate the time needed to complete or pause the task before attending to the interrupter, providing a realistic timeframe.
11 slide narrated PowerPoint presentation focused on medication safety practices.
Eligibility Criteria
You may qualify if:
- A convenience sample of new graduate nurses within the first year of practice as a nurse.
You may not qualify if:
- nurses with \>1 year of practice
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Baystate Medical Center
Springfield, Massachusetts, 01199, United States
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Nursing Research
Study Record Dates
First Submitted
May 11, 2026
First Posted
May 20, 2026
Study Start
May 13, 2024
Primary Completion
September 25, 2024
Study Completion
September 25, 2024
Last Updated
May 20, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared in accordance with institutional and IRB data sharing policies.